***MEDIA ADVISORY FOR MONDAY, AUGUST 28 AT 11:00 AM ET***
Speakers to Discuss Drug Companies’ Ongoing Efforts to Protect Their Profits, the Popularity of Negotiation, and Legal Threats to the Law
Washington, DC — On Monday, August 28, 2023, at 11:00 AM ET, legal expert William Schultz, Director of Brookings Schaeffer Initiative on Health Policy Dr. Richard Frank, and Hart Research’s Geoff Garin will join a press call with Protect Our Care to discuss the current state of play as the Biden administration is posed to announce the first 10 drugs selected for Medicare negotiation under the Inflation Reduction Act. During the event, speakers will discuss what this important step means for the American people, ongoing threats to the program, and how Medicare negotiation remains central to the Inflation Reduction Act’s popularity.
This week, CMS is expected to announce the first round of drugs eligible for lower prices under the Medicare Drug Negotiation Program, which will lower prices for millions of seniors. As the Biden administration is working to implement this core provision of the Inflation Reduction Act, big drug companies are going to court to protect their profits. The Pharmaceutical Research and Manufacturers of America (PhRMA), Chambers of Commerce, Merck, Bristol Myers Squibb, Astellas Pharma, and Johnson & Johnson-owned Janssen Pharmaceuticals have all filed lawsuits against the federal government challenging the constitutionality of the Inflation Reduction Act’s Medicare Prescription Drug Negotiation Program.
William Schultz, Partner, Zuckerman Spaeder, former General Counsel, Department of Health and Human Services
Dr. Richard Frank, Director, Brookings Schaeffer Initiative on Health Policy
Geoff Garin, President of Hart Research
Leslie Dach, Chair of Protect Our Care
WHAT: Virtual Press Conference
WHERE: Register for the Event Here
WHEN: Monday, August 28, 2023 at 11:00 AM ET